McCombe, A., Baguley, D., Coles, R., McKenna, L., McKinney, C. and Windle-Taylor, P. (2001) Guidelines for the Grading of Tinnitus Severity: The Results of a Working Group Commissioned by the British Association of Otolaryngologists, Head and Neck Surgeons, 1999. Clinical Otolaryngology & Allied Sciences, 26, 388-393.
http://www.ncbi.nlm.nih.gov/pubmed/11678946
http://dx.doi.org/10.1046/j.1365-2273.2001.00490.x

has been cited by the following article:

• TITLE: Role of Intratympanic Steroids in the Management of Meniere’s Disease—A Review of 151 Cases

  AUTHORS: D. S. Deenadayal, D. Vidyasagar, Vyshanavi Bommakanti, Karuna Goel, Nabeelah Naeem

  KEYWORDS: Meniere’s, Intratympanic Steroids, Methyl Prednisolone

  JOURNAL NAME: International Journal of Otolaryngology and Head & Neck Surgery, Vol.5 No.2, March 24, 2016

  ABSTRACT: Objective: To assess the outcomes of hearing and vertigo in patients with Meniere’s disease who were treated with intratympanic methylprednisolone. Study Design: Retrospective study. Setting: Tertiary referral hospital. Methods: In our study with 151 patients [191 ears] were diagnosed as Menieres as per 1995 AAO-HNS guidelines. As an office based procedure these patients were treated with intratympanic methyl prednisolone. Results: There was a 98.6% improvement in the vertigo control rate, a 73.82% improvement in hearing and 29.31% had a definitive improvement in tinnitus. Conclusion: We conclude from our study that intratympanic steroid injection significantly controls vertigo, tinnitus and improves hearing in Meniere’s disease with minimal complications. Hence, it can be tried as a first line treatment for patients with Meniere’s disease.